-+ 0.00%
-+ 0.00%
-+ 0.00%

Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $50.584M Est

Benzinga·08/11/2026 20:01:42
Listen to the news
Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $50.584 million estimate.